Sessa Capital IM, L.P.
Source: SEC Form 13F · as of Mar 2026Sessa Capital IM, L.P. holds 3 biotech & pharma companies tracked by BioSniper, totaling $43.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
3
Total value held
$43.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for LEXICON PHARMACEUTICALS, INC. (LXRX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| LXRXLEXICON PHARMACEUTICALS, INC. | 17,912,961 | $27.9M |
| SABSSAB BIOTHERAPEUTICS, INC. | 2,198,457 | $8.4M |
| RNAAtrium Therapeutics Inc. | 551,391 | $7.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.